Drosana 20 0.02 mg - 3 mg film-coat. tabl. Bỉ - Tiếng Anh - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

drosana 20 0.02 mg - 3 mg film-coat. tabl.

gedeon richter plc - drospirenone 3 mg; ethinylestradiol 0,02 mg - film-coated tablet - 0,02 mg - 3 mg - ethinylestradiol 0.02 mg; drospirenone 3 mg - drospirenone and ethinylestradiol

Margotviatris 20 0.02 mg - 3 mg film-coat. tabl. Bỉ - Tiếng Anh - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

margotviatris 20 0.02 mg - 3 mg film-coat. tabl.

viatris gx bv-srl - ethinylestradiol 0,02 mg; drospirenone 3 mg - film-coated tablet - 0,02 mg - 3 mg - drospirenone 3 mg; ethinylestradiol 0.02 mg - drospirenone and ethinylestradiol

Perynella 0.02 mg - 3 mg film-coat. tabl. Bỉ - Tiếng Anh - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

perynella 0.02 mg - 3 mg film-coat. tabl.

exeltis germany gmbh - ethinylestradiol 0,02 mg; drospirenone 3 mg - film-coated tablet - 0,02 mg - 3 mg - drospirenone 3 mg; ethinylestradiol 0.02 mg - drospirenone and ethinylestradiol

Yadere 0.02 mg - 3 mg film-coat. tabl. Bỉ - Tiếng Anh - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

yadere 0.02 mg - 3 mg film-coat. tabl.

theramex ireland ltd. - drospirenone 3 mg (pink tablet); ethinylestradiol 0,02 mg (pink tablet); placebo (white tablet) - film-coated tablet - 0,02 mg - 3 mg - ethinylestradiol 0.02 mg; drospirenone 3 mg; placebo - drospirenone and ethinylestradiol

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS Canada - Tiếng Anh - Health Canada

drospirenone and ethinyl estradiol tablets

mylan pharmaceuticals ulc - drospirenone; ethinyl estradiol - tablet - 3mg; 0.02mg - drospirenone 3mg; ethinyl estradiol 0.02mg - contraceptives

Ethinylestradiol / Drospirenone Leon Farma & Placebo 0.03 mg/ 3 mg Film-coated Tablets Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

ethinylestradiol / drospirenone leon farma & placebo 0.03 mg/ 3 mg film-coated tablets

laboratorios leon farma, s.a. - drospirenone; ethinylestradiol - film-coated tablet - 0.03 mg/3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol

Lucette 0.03mg/3mg tablets Vương quốc Anh - Tiếng Anh - MHRA (Medicines & Healthcare Products Regulatory Agency)

lucette 0.03mg/3mg tablets

gedeon richter (uk) ltd - drospirenone; ethinylestradiol - oral tablet - 3mg ; 30microgram

NEXTSTELLIS estetrol (as monohydrate) 14.2 mg / drospirenone 3 mg tablet blister pack Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

nextstellis estetrol (as monohydrate) 14.2 mg / drospirenone 3 mg tablet blister pack

mayne pharma international pty ltd - estetrol monohydrate, quantity: 15 mg (equivalent: estetrol, qty 14.2 mg); drospirenone, quantity: 3 mg - tablet, film coated - excipient ingredients: magnesium stearate; titanium dioxide; hypromellose; hyprolose; purified talc; hydrogenated cottonseed oil; lactose monohydrate; maize starch - nextstellis is indicated for use by women of reproductive potential to prevent pregnancy.

VESTURA- drospirenone and ethinyl estradiol Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

vestura- drospirenone and ethinyl estradiol

actavis pharma, inc. - drospirenone (unii: n295j34a25) (drospirenone - unii:n295j34a25), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - drospirenone 3 mg - vestura is indicated for use by women to prevent pregnancy. vestura is also indicated for the treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who choose to use an oral contraceptive as their method of contraception. the effectiveness of vestura for pmdd when used for more than three menstrual cycles has not been evaluated. the essential features of pmdd according to the diagnostic and statistical manual-4th edition (dsm-iv) include markedly depressed mood, anxiety or tension, affective lability, and persistent anger or irritability. other features include decreased interest in usual activities, difficulty concentrating, lack of energy, change in appetite or sleep, and feeling out of control. physical symptoms associated with pmdd include breast tenderness, headache, joint and muscle pain, bloating and weight gain. in this disorder, these symptoms occur regularly during the luteal phase and remit within a few days following onset of menses; the disturbance markedly interferes with work

Myelle 0.02 mg/3 mg tablets Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

myelle 0.02 mg/3 mg tablets

mcdermott laboratories ltd t/a gerard laboratories - drospirenone; ethinylestradiol - tablet - 0.02mg/3 milligram(s) - drospirenone and ethinylestradiol